Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475007 · ClinicalTrials.gov registry record · NA
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A NA study of COPD and Emphysema, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- NA
- Development phase
- 277
- Enrollment target
- 20
- Study locations
NCT00475007 is a NA study of COPD and Emphysema that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 277 participants, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT00475007, a NA study of COPD and Emphysema, has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 277 participants
- Enrollment target
- 20
- Study locations
Study Summary
This trial is for men and women between the ages of 40 and 74 who have a confirmed diagnosis of emphysema. The objective of the trial is to determine the safety and effectiveness of the IBV Valve at redirecting airflow from diseased portions of the lung to healthier areas to achieve improvement in disease-related health status.
Interventions
- DEVICE IBV® Valve System
Study Locations (20)
California
- Kaiser Permanente Medical Center - Los Angeles
- University of California Los Angeles (UCLA) - Los Angeles
- Mission Internal Medicine Group - Mission Viejo
- University of California Davis Medical Center - Sacramento
- University of California San Diego - San Diego
Illinois
- University of Chicago - Chicago
- Alexian Brothers Hospital Network - Elk Grove Village
- Southern Illinois University School of Medicine - Springfield
Florida
- University of Florida - Gainesville
- Sarasota Memorial Hospital - Sarasota
New York
- Mount Sinai School of Medicine - New York
- Columbia University Medical Center - New York
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- National Jewish Medical & Research Center - Denver
Georgia
- Emory HealthCare - Atlanta
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2007-09 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00475007
The ClinicalTrials.gov registry entry for NCT00475007 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (89% lower). The listed sponsor is Olympus Corporation of the Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which IBV® Valve System is the first listed.
NCT00475007 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT00475007 about?
NCT00475007 is a clinical study titled "Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema". This trial is for men and women between the ages of 40 and 74 who have a confirmed diagnosis of emphysema. The objective of the trial is to determine the safety and effectiveness of the IBV Valve at redirecting airflow from diseased portions of the lung to healthier areas to achieve improvement in d...
What is the current status of trial NCT00475007?
This trial is currently completed. It is a NA study. The enrollment target is 277 participants. The study started on 2007-09. Estimated completion is 2017-08.
What conditions does trial NCT00475007 study?
This clinical trial studies the following conditions: COPD, Emphysema.
What interventions are being tested in trial NCT00475007?
The interventions under investigation include: IBV® Valve System (DEVICE).
Who is sponsoring clinical trial NCT00475007?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00475007 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.